LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Pulmonx Corporation

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERLUNG
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / LUNG COVERAGE

What’s moving Pulmonx Corporation now

Current reporting with the operating signal separated from the noise.

01
Pulmonx Corporation (LUNG) Q2 2026 Earnings Call Transcript

Pulmonx Corporation (LUNG) Q2 2026 Earnings Call Transcript

Investors are testing whether Pulmonx Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results

Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results

The story matters when it changes Pulmonx Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Pulmonx Corporation (LUNG) reports Q2 loss, beats revenue estimates

Pulmonx Corporation (LUNG) reports Q2 loss, beats revenue estimates

Investors are testing whether Pulmonx Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The story matters when it changes Pulmonx Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Pulmonx Corporation Announces First Quarter 2025 Financial Results Release and Conference Call Details

Pulmonx Corporation Announces First Quarter 2025 Financial Results Release and Conference Call Details

The development tests whether Pulmonx Corporation can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest LUNG filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-04 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-10 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-29 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-06-04 · Period 2026-06-04SEC ↗8-KMaterial company eventFiled 2026-04-29 · Period 2026-04-29SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-22 · Period 2026-06-04SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-29SEC ↗
EARNINGS / QUARTERLY TRACKER

Pulmonx Corporation, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.